Literature DB >> 557787

Prepubertal XY gonadal dysgenesis.

K Isurugi, Y Aso, H Ishida, T Suzuki, T Kakizoe, T Motegi, T Nishi, H Aoki.   

Abstract

Two children had prepubertal XY gonadal dysgenesis. A 7-year-old girl with clitoral enlargement had a left ovarian tumor that contained a dysgerminoma; the right gonad proved to be a gonadoblastoma. The second child (a 2-year-old girl) showed poor physical development and slight virilization of the genitalia. Her bilateral dysgenetic gonads were removed at exploratory laparotomy. The occurrence of gonadal tumors in XY gonadal dysgenesis is increased. It is probably related to the hypergonadotropinism existing from childhood as well as to genetic predisposition of the cryptorchid testis in the presence of a Y chromosome. Our first patient is one of the youngest who had XY gonadal dysgenesis iwth gonadoblastoma reported. The indication of prophylactic gonadectomy in XY gonadal dysgenesis is emphasized.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 557787

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  4 in total

1.  Prepubertal gonadoblastoma in a 46,XY female patient with features of Turner syndrome.

Authors:  A Alikaşifoğlu; N Kandemir; M Cağlar; E Kotiloğlu; N Yordam
Journal:  Eur J Pediatr       Date:  1996-08       Impact factor: 3.183

2.  Nonfluorescent Y chromosomes. Cytologic evidence of origin.

Authors:  E Magenis; T Donlon
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

Review 3.  Localisation of male determining factors in man: a thorough review of structural anomalies of the Y chromosome.

Authors:  R M Davis
Journal:  J Med Genet       Date:  1981-06       Impact factor: 6.318

4.  The X linked recessive form of XY gonadal dysgenesis with a high incidence of gonadal germ cell tumours: clinical and genetic studies.

Authors:  J R Mann; J J Corkery; H J Fisher; A H Cameron; A Mayerová; U Wolf; A A Kennaugh; V Woolley
Journal:  J Med Genet       Date:  1983-08       Impact factor: 6.318

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.